Northern Trust Corp Acquires 5,090 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Northern Trust Corp increased its holdings in shares of Viemed Healthcare, Inc. (NASDAQ:VMD) by 1.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 286,818 shares of the company’s stock after purchasing an additional 5,090 shares during the period. Northern Trust Corp owned approximately 0.74% of Viemed Healthcare worth $2,300,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. Renaissance Technologies LLC lifted its stake in Viemed Healthcare by 2.3% in the 4th quarter. Renaissance Technologies LLC now owns 373,000 shares of the company’s stock valued at $2,991,000 after acquiring an additional 8,400 shares in the last quarter. Bard Associates Inc. lifted its stake in Viemed Healthcare by 1.3% in the 4th quarter. Bard Associates Inc. now owns 349,526 shares of the company’s stock valued at $2,803,000 after acquiring an additional 4,474 shares in the last quarter. First Eagle Investment Management LLC lifted its stake in Viemed Healthcare by 196.5% in the 4th quarter. First Eagle Investment Management LLC now owns 328,824 shares of the company’s stock valued at $2,637,000 after acquiring an additional 217,923 shares in the last quarter. Rice Hall James & Associates LLC bought a new stake in Viemed Healthcare in the 4th quarter valued at approximately $2,083,000. Finally, JPMorgan Chase & Co. lifted its stake in Viemed Healthcare by 131.4% in the 4th quarter. JPMorgan Chase & Co. now owns 228,652 shares of the company’s stock valued at $1,834,000 after acquiring an additional 129,854 shares in the last quarter. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Trading Down 1.5%

NASDAQ VMD opened at $6.42 on Monday. The stock has a market capitalization of $253.74 million, a price-to-earnings ratio of 23.78 and a beta of 1.49. The stock’s 50 day moving average price is $6.89 and its two-hundred day moving average price is $7.75. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. Viemed Healthcare, Inc. has a 52 week low of $6.14 and a 52 week high of $9.81.

Viemed Healthcare (NASDAQ:VMD) last released its earnings results on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The firm had revenue of $59.10 million for the quarter, compared to analysts’ expectations of $60.60 million.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.